T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy

被引:111
|
作者
Franco, JM
Rubio, A
Martínez-Moya, M
Leal, M
Merchante, E
Sánchez-Quijano, A
Lissen, E
机构
[1] Hosp U Virgen Rocio, Dept Med Interna, Viral Hepatitis & AIDS Study Grp, Seville 41013, Spain
[2] Hosp U Virgen Rocio, Dept Radiol, Seville 41013, Spain
关键词
D O I
10.1182/blood.V99.10.3702
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The origin of T cells after highly active antiretroviral therapy (HAART) in patients infected with human immunodeficiency virus 1 (HIV-1) is now under discussion. The possibility of renewed lymphopoiesis in aged thymuses is still controversial. In this work we combine the analysis of naive T cells, T-cell receptor excision circles (TRECs), and computed tomography scanning of thymic tissue to further assess whether the thymus is involved in immune reconstitution. Fifteen antiretroviral-naive HIV-1-infected patients were evaluated during 48 weeks of HAART. At baseline, significant correlation was present among age and both thymic volume and TRECs, and between naive T cells and TRECs. After starting HAART, there was a significant increase at week 12 in naive CD4(+) and CD8(+) T cells, TRECs, and thymic volume. The initial net Increases in naive T cells and TREC counts were significantly correlated. Changes In thymic volume and TRECs were also indirectly related; splitting the population Into 2 groups of high and low baseline levels, only the group with low TREC levels had significant increases In both TRECs and thymic volume. Thus, the Increase in thymic volume might be functional, In response to depleted TREC levels. Taken together, our data strongly suggest a thymic role In Immune reconstitution, at least in patients with depleted baseline TREC levels. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:3702 / 3706
页数:5
相关论文
共 50 条
  • [21] The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy
    Dyrhol-Riise, AM
    Stent, G
    Rosok, BI
    Voltersvik, P
    Olofsson, J
    Åsjö, B
    [J]. CLINICAL IMMUNOLOGY, 2001, 101 (02) : 169 - 179
  • [22] Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children
    Wamalwa, Dalton C.
    Farquhar, Carey
    Obimbo, Elizabeth M.
    Selig, Sara
    Mbori-Ngacha, Dorothy A.
    Richardson, Barbra A.
    Overbaugh, Julie
    Emery, Sandy
    Wariua, Grace
    Gichuhi, Christine
    Bosire, Rose
    John-Stewart, Grace
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (03) : 311 - 317
  • [23] Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy
    Parera, M
    Ibáñez, A
    Clotet, B
    Martinez, MA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (08): : 1444 - 1451
  • [24] Changes in thymus volume in adult HIV-infected patients under HAART:: correlation with the T-cell repopulation
    Rubio, A
    Martínez-Moya, M
    Leal, M
    Franco, JM
    Ruiz-Mateos, E
    Merchante, E
    Sánchez-Quijano, A
    Lissen, E
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (01): : 121 - 126
  • [25] Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients
    Ibáñez, A
    Puig, T
    Elias, J
    Clotet, B
    Ruiz, L
    Martínez, MA
    [J]. AIDS, 1999, 13 (09) : 1045 - 1049
  • [26] Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy
    Rousseau, MN
    Vergne, L
    Montes, B
    Peeters, M
    Reynes, J
    Delaporte, E
    Segondy, M
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (01) : 36 - 43
  • [27] Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands
    Nellen, JF
    Wit, FW
    de Wolf, F
    Jurriaans, S
    Lange, JM
    Prins, JM
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (04) : 943 - 950
  • [28] CCR5 Δ32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients
    Guérin, S
    Meyer, L
    Theodorou, I
    Boufassa, F
    Magierowska, M
    Goujard, C
    Rouzioux, C
    Debré, P
    Delfraissy, JF
    [J]. AIDS, 2000, 14 (17) : 2788 - 2790
  • [29] Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies
    Egger, M
    May, M
    Chêne, G
    Phillips, AN
    Ledergerber, B
    Dabis, F
    Costagliola, D
    Monforte, AD
    de Wolf, F
    Reiss, P
    Lundgren, JD
    Justice, AC
    Staszewski, S
    Leport, C
    Hogg, RS
    Sabin, CA
    Gill, MJ
    Salzberger, B
    Sterne, JAC
    [J]. LANCET, 2002, 360 (9327): : 119 - 129
  • [30] Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study
    Hung, CC
    Hsiao, CF
    Wang, JL
    Chen, MY
    Hsieh, ZM
    Sheng, WH
    Chang, SC
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (10) : 673 - 676